Prosecution Insights
Last updated: May 29, 2026

Examiner: CHOUDHURY, NURA MANSURA

Tech Center 2800 • Art Units: 1683 2872

This examiner grants 100% of resolved cases

Performance Statistics

100.0%
Allow Rate
+32.0% vs TC avg
11
Total Applications
+0.0%
Interview Lift
1266
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
0%
§102 Novelty
88.9%
§103 Obviousness
0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18360135 METHODS AND COMPOSITIONS FOR IN SITU ANALYSIS USING TIME-GATED DETECTION Non-Final OA 10x Genomics, Inc.
18213214 METHOD FOR ENZYMATIC DISSOCIATION OF HYBRIDIZED PROBES IN SITU Non-Final OA 10x Genomics, Inc.
18209350 USE OF HOMOLOGOUS RECOMBINASE TO IMPROVE EFFICIENCY AND SENSITIVITY OF SINGLE CELL ASSAYS Non-Final OA Bio-Rad Laboratories, Inc.
17811812 Method for Determining Sensitivity to 2,2'-Dithio-bis-Ethane Sulfonate Final Rejection Lantern Pharma Inc.
18200582 METHOD AND KIT FOR SIMULTANEOUSLY DETECTING A PLURALITY OF DIFFERENT PATHOGENS IN A SAMPLE Non-Final OA XEBIOS DIAGNOSTICS GROUP GMBH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month